To assess wether methylphenidate reduces the prevalence of primary nocturnal enuresis in children with attention deficit disorder
Children aged 5 - 10 years newly diagnosed with attention deficit hyperactivity disorder who report primary nocturnal enuresis, Investigators will obtain baseline data (from parents/caregivers) on their sleep habits and enuresis characteristics by questionnaire. After 6 weeks of methylphenidate therapy, prescribed for the attention deficit, a new questionnaire will be filled.
Study Type
OBSERVATIONAL
Enrollment
50
The drug will be prescribed as indicated for attention deficit disorder
Meir Medical Center
Kfar Saba, Israel
RECRUITINGA reduction in nocturnal enuresis frequency
Time frame: 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.